Labcorp Holdings (LH) Non-Current Deffered Revenue (2014 - 2015)
Labcorp Holdings (LH) posted Non-Current Deffered Revenue of $46.4 million for Q4 2015, up 1264.71% sequentially from $3.4 million in Q4 2014, and up 1264.71% YoY from $3.4 million in Q4 2014.
Labcorp Holdings (LH) Non-Current Deffered Revenue (2014 - 2015) Analysis & Trends
Labcorp Holdings has reported Non-Current Deffered Revenue for 2 years, with the latest figure at $46.4 million in Q4 2015.
- Quarterly Non-Current Deffered Revenue rose 1264.71% year-over-year to $46.4 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $46.4 million (up 1264.71% YoY) and the FY2015 annual result came in at $46.4 million, up 1264.71% from the prior year.
- Non-Current Deffered Revenue climbed to $46.4 million in Q4 2015 per LH's latest filing, from $3.4 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $46.4 million in Q4 2015 and troughed at $3.4 million in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 16.07 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 32.59 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | - |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 46.40 Mn |
| Dec 31, 2014 | 43.40 Mn |